These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12120213)

  • 21. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of chronic pancreatitis from pancreatic cancer: recent advances in molecular diagnosis.
    Ebert M; Schandl L; Schmid RM
    Dig Dis; 2001; 19(1):32-6. PubMed ID: 11385249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.
    Löhr M; Schmidt C; Ringel J; Kluth M; Müller P; Nizze H; Jesnowski R
    Cancer Res; 2001 Jan; 61(2):550-5. PubMed ID: 11212248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
    Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
    Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crucial role of fibrogenesis in pancreatic diseases.
    Jaster R; Emmrich J
    Best Pract Res Clin Gastroenterol; 2008; 22(1):17-29. PubMed ID: 18206810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
    Zhang Y; Dang C; Ma Q; Shimahara Y
    Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New molecular targets in pancreatic cancer].
    Torrisani J; Bournet B; Cordelier P; Buscail L
    Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidermal growth factor receptor in human pancreatic cancer.
    Lemoine NR; Hughes CM; Barton CM; Poulsom R; Jeffery RE; Klöppel G; Hall PA; Gullick WJ
    J Pathol; 1992 Jan; 166(1):7-12. PubMed ID: 1538276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
    Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
    Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of prostatic growth and function by peptide growth factors.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
    Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-step pancreatic carcinogenesis and its clinical implications.
    Sakorafas GH; Tsiotou AG
    Eur J Surg Oncol; 1999 Dec; 25(6):562-5. PubMed ID: 10555999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.
    Künzli BM; Berberat PO; Giese T; Csizmadia E; Kaczmarek E; Baker C; Halaceli I; Büchler MW; Friess H; Robson SC
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G223-30. PubMed ID: 16920697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes.
    Lomberk G
    Pancreatology; 2009; 9(3):200-2. PubMed ID: 19299909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth factors and their receptors in pancreatic cancer.
    Ozawa F; Friess H; Tempia-Caliera A; Kleeff J; Büchler MW
    Teratog Carcinog Mutagen; 2001; 21(1):27-44. PubMed ID: 11135319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth factors and cytokines in pancreatic carcinogenesis.
    Friess H; Guo XZ; Nan BC; Kleeff J; Büchler MW
    Ann N Y Acad Sci; 1999 Jun; 880():110-21. PubMed ID: 10415856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-β in pancreatic diseases: Mechanisms and therapeutic potential.
    Zhou Q; Xia S; Guo F; Hu F; Wang Z; Ni Y; Wei T; Xiang H; Shang D
    Pharmacol Res; 2019 Apr; 142():58-69. PubMed ID: 30682425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [NO and pancreatic diseases].
    Shimosegawa T; Toyota T
    Nihon Shokakibyo Gakkai Zasshi; 1999 Aug; 96(8):923-32. PubMed ID: 10481480
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth factor mediated signaling in pancreatic pathogenesis.
    Nandy D; Mukhopadhyay D
    Cancers (Basel); 2011 Feb; 3(1):841-71. PubMed ID: 24212642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic pancreatitis--new pathophysiological concepts.
    Berberat PO; Friess H; Büchler MW
    Swiss Surg; 2000; 6(5):227-30. PubMed ID: 11077486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of pancreatic steatosis.
    Smits MM; van Geenen EJ
    Nat Rev Gastroenterol Hepatol; 2011 Mar; 8(3):169-77. PubMed ID: 21304475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.